chrisvoncsefalvay/vaers-outcomes huggingface dataset:
There is a slightly tender, warm, erythematous macule over the left lateral thigh, about 5 x 8 cm in size.  It is slightly elevated.
Vaccines administered yesterday 12/03/2003, no status symptoms of any adverse reactions at this date, child came home from school and had a reddened area splotchy over entire deltoid area.  Clients aunt called instructed to put ice on it.  Benadryl 3/4 tsp given to cont giving Benadryl tonight and in AM.  See MD, brought in by grandmother 12/04 @ 16:15.  12/11/2003: Family states child well, did not see MD.
SLIGHT CHILL; TIRED; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced slight chill, and tired. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight chill, and tired. This report was non-serious.
Developed severe cough and mucous production approx. 2 hours after receiving the vaccine. (Same symptoms occured last year after the flu vaccine while pregnant)  Self medicated with Benaddryl oral.
First I got chill after second shot vaccine, that it pass quick on me. That worst just begin I safer every day to get up from the bad. Get up with sharp pain in my shoulder where was shot. And that hand is right, I have to go to work. Its been 2,5 month and I still safer, sometime my joint stiff, my hand all the time stiff. I can not wait to release that pain. I I knew I will go though that I would never do that vaccine. I am ashamed to tell friends and co-workers that i am hurt so much. I am taking Aleve or ibuprofen every day, trying to not take too much as I have medical conditions. I am afraid to lay down because i do not know if I can get up. Its nightmare when is the end?
Backache; Chills; Slight headache; Feverish; Pins and needles all over body; This is a spontaneous report from a contactable healthcare professional. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 hours (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, COVID-19 infection and right knee replacement. It was unknown if the patient had known allergies to medications, food or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 40 mg, for unknown indication, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 12:00, the patient experienced backache, chills, slight headache, feverish and pins and needles all over body. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events backache, chills, slight headache, feverish and pins and needles all over body was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
On the day after vaccination, rather severe hive on the entire back only. Dr. prescribed prednisone 20mg tabs on 11-2-15.
Chills for approx. 30 hours Soreness at injection site appearing 12 hours post and lasting 48 + post
Patient fainted within minutes of receiving the vaccine.  He recovered quickly and leaned on a family family for about 30 minutes sitting down.  He felt alright standing up after that and left the pharmacy.
ended up passing out right there; feeling hands and legs num; feeling very week; having hard time eating or drinking anything; This is a spontaneous report from a contactable consumer(patient). A 19-year-old female patient(not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 07May2021 03:30 (Lot Number: EW0158) as 2nd dose, single for covid-19 immunization. Medical history and concomitant medications were none. There was no other vaccines within 4 weeks prior to the COVID vaccine, no other medications the patient received within 2 weeks of vaccination. There was no known allergy. She was not diagnosed with COVID-19. Historical vaccine included first dose of BNT162B2 on 15Apr2021 at 03:00(Lot No.: EWO173) in arm left for COVID-19 immunisation. It was stated that 2 days after the second dose, on 09May2021 she was at work and start feeling hands and legs num . She was at the cashier and ended up passing out right there. She was rushed to ER(Emergency room) and she could feel or move her last for at least 30 minutes. She was afraid she would not be able to walk again. She was treated and after 3-4 hours they discharged herself saying it was a reaction to the vaccine. She had been home since then and still (4 days after the shot ) having a hard time eating, or drinking anything in May2021. She was still feeling very week in May2021. Treatment for ended up passing out right there, feeling hands and legs num included just a bunch of exams were done and everything see in May2021. Outcome of ended up passing out right there, feeling hands and legs num was recovering, of other events was not recovered.
Patient received H1N1 vaccine approx 9:40 AM on 12/24/09. Once the patient stood up, patient felt dizzy. R.PH told her to sit down. 5 min later, R.PH gave her some water. Approx. 10 min later, R.PH checked on her. Patient felt just a little lightheaded and area of injection was red, bit swollen, and warm. RPH brought out Blood pressure monitor. Got 3 readings. Last reading was 124/107 at 10:32 AM. Pt refused epipen and will be taking BENADRYL.
Case number PHEH2016US023439, is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 24 years old patient of unknown gender. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscularly in left arm on 01 Dec 2015. On 01 Dec 2015, FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursions was administered to patient. The nurse stated that, no adverse event was reported following this administration error (incorrect product storage). The case was assessed as non serious by the nurse.
first dose in 2019 did not receive second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (might have received the 1st dose in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Pharmacist reported a patient did not received the 2nd dose of Shingrix till the time of reporting which led to incomplete course of vaccination.  Reporter had no other details or even if there was a patient.  The reporter consented to follow up via email.
An injection of PNEUMOVAX 23 left extreme pain with immobilization of the left arm from the injection area to the elbow.  The day following the injection Dr. of the same facility examined patient and diagnosed a severe reaction to the vaccine resulting in muscle breakdown.  Prescribed 20mg prednisone daily and propoxyphen-APAP for pain.  As of this date (5/16) there is some improvement and ability to move the arm slightly with some pain.
My whole arm was sore. I started running a fever. I had the cold sweats. I also had shortness of breath. I also vomited. I started coughing and phlegm was coming up. I was also light-headed and dizzy. I went to the emergency room the next evening I they gave me fluids for dehydration. They also gave me magnezium because it was low. Then they gave me some antibiotics interveniosly to fight off the pneumonia that I got as a result of the shot.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not provided. On 16-AUG-2018, the patient was vaccinated with expired PNEUMOVAX 23 lot # M040804, expiration date 20-MAY-2018, for prophylaxis (route of administration and exact dose were not provided). No adverse event reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1808USA008493.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021 at 11:38 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Mar-2021 at 11:45 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 53.36 for dose administered on 14-Feb-2021 and 53.45 for dose administered on 21-Mar-2021. No concomitant and treatment medications were reported. Batch number 031L20A (dose -1) underwent temperature excursion on 14-Feb-2021 with temperature 32,32,32,35,35 degrees Fahrenheit from 09:00 AM to 3:00PM. This vial was moved to fridge on 09-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 13-Jan-2021.  Batch number 003B21A (dose -2) underwent temperature excursion on 21-Mar-2021 with temperature 34,32,34 degrees Fahrenheit from 09:00 AM to 11:00 AM. This vial was moved to fridge on 16-Mar-2021 and beyond use date for the vial was reported as 15-Apr-2021. Product moved to clinic on 21-Mar-2021.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.   This case was linked to MOD-2022-566976 (Patient Link).
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Patient has a knot at injection site-Severe, Additional Details: Patient had a knot at injection site as well as excessive bleeding. Patient is not on blood thinners. After 7 days, the knot still exist and there is slight pain, and redness
total body swelling (puffy) & achy all over pain in joints; treated w/Naprocin;
Pt received Prevnar #1 on 1/5/01 and mother noticed urticarial, erythematous, maculo-papular rash all over body, including face, the next morning, post vax. No other triggering factor noted except that the pt wore a new pajama set that night. Rx'd with Benadryl and hydrocortisone cream.
Mother called AM of 11/15/07 and stated patient could not move his arm.  When questioned further she state patient can move arm but complaining of pain at injection site, redness and swelling. Injection site was right arm
Information has been received from a physician concerning an 87 year old male patient with high cholesterol, coronary artery disease (CAD), atrial fibrillation (Afib), peripheral vascular disorder (PVD), vitamin d insufficiency, left eye scleritis, mitral regurgitation(MR), tricuspid regurgitation(TR), pulmonary hypertension, hypertension, chronic kidney disease stage 3(CKD)and impaired fasting glucose who on 17-FEB-2011 was vaccinated with a 0.65 mL dose (reported as standard dose) of ZOSTAVAX (Merck)(lot#: 669533/1382Z) for preventing shingles. Concomitant therapy included COREG, ALTACE, simvastatin (MSD), warfarin, aspirin, vitamin D (unspecified), cyanocobalamin (manufacturer unknown) and DULCOLAX. It was reported that the patient developed shingles a couple of days ago. According to the patient the rash developed on 02-JUL-2012 and he went to the doctor on Monday, 04-JUN-2012, and that's when it was diagnosed. The patient was given a prescription for VALTREX on 04-JUN-2012 and was assumed he started taking it. No lab diagnostics studies performed. At the time of the report, the patient was recovering. Follow up information was received from a health care professional reporting that the 87 year old retired male patient on 17-FEB-2011, was vaccinated in his left deltoid with the first 0.65 dose of ZOSTAVAX (Lot # 669533/1383Z, Expiration date 19-JAN-2012). It was reported that the rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. The patient had a history of chickenpox during his childhood and in May-2012, was exposed to chickenpox or herpes zoster. Direct fluorescent antibody was not performed. No specimen was collected for polymerase chain reaction (PCR). It was reported that reddish rash that was somewhat painful and pruritic having stated on 02-JUN-2012, it had not significantly worsened. The patient had not associated fever or chills other areas of rash or new contacts or exposures. The denied any discomfort or itching this morning. He did have a slightly erythematous rash over the right anterior chest surrounding the mid right breast medially. It was reported that patient's daughter was recently diagnosed (May-2012) with varicella zoster. Additional information has been requested.
numb tongue; This is a spontaneous report from a contactable nurse. A patient of unspecified age and gender received bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced numb tongue on an unspecified date. Event took place after use of product. The outcome of event was unknown.  Information on the Lot/Batch number has been requested.
EXTREME muscle pain and fatigue, even with over the counter pain reliever (Advil). As of this point (12:00 noon on 12/2/2010) it is getting worse...
Starting the 9th day (well, noticed on the 9th day), rash began to form on the underside/palm of right hand in small red dots. Next day to today (3 days), small red dots have grown on right hand and more small dots have developed on underside of left hand, right elbow, left elbow, and bottom of left foot.
pain, redness and swelling at injection site and streaking towards axillary and then turned into red patches 6inX6in on left arm, patient was monitored over the course of a week, no treatment given
Awoke in AM with pimple like area noted on right rib cage.  Pain started shortly thereafter and a few more bumps appeared.  Seen by MD 2/28/12 diagnosed with shingles.  MD added he did not feel vaccine contributed to outbreak.  Prescribed anti-viral medication, pain med.  Additional area of rash developed on right upper arm early 2/29/12.
Patient felt hot, dizzy and nauseated about 10 minutes after receiving Moderna booster vaccine. She did not appear anxious or nervous at the time of vaccination. She tolerated the first and second vaccines well. She appears to be ok now.
I contracted Covid-19 two months after getting my second dose with symptoms; I contracted Covid-19 two months after getting my second dose with symptoms; This is a spontaneous report from a contactable consumer (patient). A 29-yeas-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0171), dose 2 via an unspecified route of administration, administered in left arm on an unspecified date, as single dose and dose 1 via an unspecified route of administration, administered in left arm on 03Apr2021 (Lot Number: ER8730), as single dose for COVID-19 immunisation. The patient had no other medical history and no known allergies. The patient had no any other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient contracted COVID-19 (01Jul2021 at 10:00) two months after got her second dose with loss of taste and smell, body aches, nausea, vomiting and chills and fever while on vacation. The patient underwent lab tests and procedures which included rapid test (nasal swab): positive on 01Jul2021. Event occurred in a location different from that of the reporter. The patient did not receive treatment in response to the events. Outcome of the events was resolving.  No follow-up attempts are possible. No further information is expected.
First reaction was large painful swelling at injection site. Next day injection site was red feverish and itchy, I felt achy.  Seven days later my right hip began to hurt in the same location where I had suffered shingles in 2009.  Shingles in 2009 were in right leg quadrant.  Pain is nearly as bad as shingles attack.  Require pain-killer to sleep and have painful difficulty rising from a prone position. Feels like shingles again but without the blisters. Not sure how long this will continue.
After receiving COVID-19 vaccine 5 days ago, this employee developed pain in her left arm. This pain has continued to increase to become ?severe?. She was advised to see a provider asap.
Pain; Redness, Hot skin, Fever, Lethargy, Edema, Loss of Muscle control near injection site.
Mildly itchy rash appeared early on day 9 after the vaccination. It was near the injection site and was irregular in shape and about 1 1/2 inches wide and about 3 inches long.  On day 11 it suddenly doubled in size. It is the same size today(day 12).
COPIOUS AMOUNTS OF DIARRHEA FOR 24 HOURS POST INJECTION.
One week post vax on February 9, 1999, the pt developed some pox.
2:30 1hr p/vax pt exp a severe h/a;pt took 2 excedrin;3:30 pt had tingling in arms & chest;6:00PM n/v, mouth dryness, felt throat was closing, heaviness in chest;
Very swollen, red at site of injection.  Extremely tender to touch.  Abnormally swollen, slight rash.
Redness, swelling, pain, lymph node enlargement, tenderness, elevated temp. KEFLEX 500mg 1 TID x 7 days.
Day 1, I was fine. The next day, I felt like I had a fever but it wasn't showing per thermometer. I had shooting pain anywhere I scratched too hard. Two days later I still had nerve pain. Nine days after vaccine, I noticed the flat patch on my arm at vaccine site. Really wasn't itchy. Friday, the flat patch was elevated and swelling. Upper lip was itchy and my face was asymmetrical. I am allergic to most tree nuts, but not all. I can usually eat pecans and I did have one.  The patch grew from Thursday, and the largest it got was 5 3/4 inches. I never got a fever during all of this. I took Pepcid along with ibuprofen for treatment.
Swollen face that is black and blue; Swollen face that is black and blue; Nosebleed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Swollen face that is black and blue) and SKIN DISCOLOURATION (Swollen face that is black and blue) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced EPISTAXIS (Nosebleed). On 01-May-2021, the patient experienced SWELLING FACE (Swollen face that is black and blue) (seriousness criterion hospitalization) and SKIN DISCOLOURATION (Swollen face that is black and blue) (seriousness criterion hospitalization). At the time of the report, SWELLING FACE (Swollen face that is black and blue), SKIN DISCOLOURATION (Swollen face that is black and blue) and EPISTAXIS (Nosebleed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Prednisone 20mg, Affrin, and Bacitracin, as advised by their HCP to try to alleviate the symptoms.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.